RECON BIOINFORMATICS ENGINE
Live / Registered — Registered (as of 05 Oct 2021)
What this means for you
Registered since 05 Oct 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88216669
- Registration number
- 6511835
- Mark type
- Design + words
- Filed
- 04 Dec 2018
- Published for opposition
- 09 Jul 2019
- Registered
- 05 Oct 2021
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, immunomodulators; anti-cancer preparations; biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; synthetic peptides for the treatment of cancer; and vaccine preparations
Owner
- BioNTech US Inc., Cambridge, MA, US
- BioNTech US Inc., Dover, DE, US
- Neon Therapeutics, Inc., Cambridge, MA, US
- Neon Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 28 Dec 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Dec 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Dec 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Dec 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Sept 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Aug 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Aug 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Aug 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Feb 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Feb 2021 — NON-FINAL ACTION E-MAILED
- 02 Feb 2021 — SU - NON-FINAL ACTION - WRITTEN
- 12 Jan 2021 — STATEMENT OF USE PROCESSING COMPLETE